Invenra Launched Deck Featuring Cancer Art

The Wisconsin-based firm debuted a custom playing card deck showcasing art created by patients affected by cancer.

Updated on Oct. 12, 2026 in Cancer

Invenra Launched Deck Featuring Cancer Art

Live Poll

Do you trust pharmaceutical marketing campaigns that incorporate personal patient art to build brand awareness?

Invenra has released a 52-card deck titled 52 Views of Cancer that features licensed artwork from people impacted by the disease. The project aims to motivate clinical researchers to continue their efforts toward developing new cancer cures.

Why it matters

By highlighting the human impact of cancer through patient artwork, Invenra seeks to inspire the scientific community to innovate in the field of antibody research. The company provides specialized platforms for antibody-drug conjugate (ADC) development.

The 52 Views of Cancer deck consists of 52 cards plus jokers, each showcasing licensed artwork from individuals affected by the disease.

The players

Invenra

This Wisconsin-based biotechnology company focuses on developing bispecific and trispecific antibody platforms for ADC development.

The details

Invenra displays the patient-created artwork and accompanying artist statements on a dedicated website to provide context for the imagery. The company specializes in creating bispecific and trispecific antibody platforms designed for ADC development.

Invenra debuted the deck at the World ADC Conference in October 2026.

The Big Picture

This project integrates patient-focused advocacy into the clinical pipeline for antibody-drug conjugate (ADC) development platforms. The initiative marks a departure from traditional corporate branding by using patient experiences to humanize the research process.

The initiative highlights how biotechnology companies in Madison are connecting the human experience of patients with the clinical development of new treatments. While the decks are for professional distribution, they signal a trend of incorporating patient narratives into research workflows.

The takeaway

This initiative underscores the value of maintaining a human-centered perspective when developing complex medical technologies. Researchers and clinicians can utilize these narratives to foster a stronger connection between their daily lab work and the patients they serve.